Baxter International Inc. (BAX) News

Baxter International Inc. (BAX): $80.73

0.16 (+0.20%)

POWR Rating

Component Grades













Filter BAX News Items

BAX News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

BAX News Highlights

  • For BAX, its 30 day story count is now at 53.
  • Over the past 25 days, the trend for BAX's stories per day has been choppy and unclear. It has oscillated between 1 and 12.
  • The most mentioned tickers in articles about BAX are HRC, LAW and MCG.

Latest BAX News From Around the Web

Below are the latest news stories about Baxter International Inc that investors may wish to consider to help them evaluate BAX as an investment opportunity.

Baxter's Norepinephrine Wins FDA Nod For Low Blood Pressure

The FDA has approved Baxter International Inc's (NYSE: BAX) premix norepinephrine bitartrate in 5% dextrose injection. Norepinephrine is indicated to raise blood pressure in adult patients with severe, acute hypotension (low blood pressure). According to a news release, the company's formulation of norepinephrine is the first and only manufacturer-prepared, ready-to-use formulation. The Company offers the formulation in 4 mg/250 mL (16 mcg/mL) and 8 mg/250 mL (32 mcg/mL) strengths. Baxter's form

Yahoo | September 23, 2021

Baxter Announces U.S. FDA Approval and Launch of Ready-to-use Cardiovascular Medicine Norepinephrine in Premix Formulation

DEERFIELD, Ill., September 23, 2021--Baxter announced the U.S. FDA approval and commercial launch of premix Norepinephrine Bitartrate in 5% Dextrose Injection (norepinephrine).

Yahoo | September 23, 2021

Surgical Hat Market Recent Research: Market Size, Trends & Forecasts 2021-2027 - Zoll Medical, Baxter International Inc, Zyno Medical etc.

The Surgical Hat global market research reports released by Market Strides for 2021 will help you evaluatethe correct information and verify the data to meet your needs. It can help you understand and capture the various dynamics of the industry,

OpenPR | September 22, 2021

Baxter plays down Katsande void

STUART Baxter has commented on Kaizer Chiefs apparent struggles to fill the void left by club legend Willard Katsande. Katsandes decade-long affiliation with the Amakhosi came to an end in July after the 35-year-olds contract at Naturena expired. The Zimbabwe international featured in 326 official matches for Chiefs and played an integral role in the []

The Chronicle Zimbabwe | September 21, 2021

Dedicated Infusion Pump Disposables Market 2021 Global Insights and Business Scenario Becton, Dickinson and Company (US), Baxter International, Inc. (US)

The Dedicated Infusion Pump Disposables Market report provides the overall structure and business outlook of the global and regional industries. The study also involves the important Achievements of the market, Research & Development, new product launch, product responses, and regional

OpenPR | September 20, 2021

Infection Surveillance Solutions Market Size & Share Analysis by Premier International, Inc., Wolters Kluwer N.V., Cerner Corporation, Baxter International Inc., GOJO Industries, Inc., Sunquest

Infection Surveillance Solutions Market survey offers key information about the industry, helpful and important facts and figures, expert opinions, and the latest developments across the world. The report includes data on patterns and improvements, target business sectors and materials, limits,

OpenPR | September 20, 2021

Baxter International Inc. Consensus Indicates Potential 13.2% Upside

Baxter International Inc. with ticker code (BAX) now have 14 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The target price ranges between 105 and 82 with a mean TP of 94.21. With the stocks previous close at 83.22 this would indicate that there is a potential upside of 13.2%. The 50 day moving average now sits at 77.39 while the 200 day moving average is 81.32. The market capitalisation for the company is $41,797m. Company Website: /> [stock_market_widget type="chart" symbol="BAX" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis thera...

DirectorsTalk | September 20, 2021

Ambulatory Device Market Growth, Competitive Landscape, Research Methodology and Company Profiles Forecast by 2027 are Baxter International Inc., Abbott Laboratories, BioTelemetry, Inc., ETC.

The global Ambulatory Device Market is forecasted to be worth USD 15.20 Billion by 2027, according to a current analysis by Emergen Research. Ambulatory devices are witnessing an increased demand owing to the growing preference for outpatient services and avoiding hospital stay []

iCrowdNewswire | September 20, 2021

Sterile Injectable Drugs Market 2021 by Application, Consumption, Industry Share, Growth Opportunities, Regions & Forecast by 2027 | (Impact of COVID-19) |Baxter International, Sanofi, GlaxoSmithKline

The Global Sterile Injectable Drugs Market research is an exclusive market study that provides the most up-to-date, in-depth information and thorough analysis of the market. It offers a widespread overview of the market, as well as deep insights into key elements such

OpenPR | September 18, 2021

Immunoadsorption Columns Market Overwhelming Growth by 2021-28|| Fresenius Kabi AG, Asahi Kasei Corporation, Miltenyi Biotec, Terumo Corporation, Glycorex Transplantation AB, Baxter International Inc., POCARD Ltd

Immunoadsorption is an extracorporeal technique used for the removal of antibodies and molecules from the blood. Immunoadsorption is the further development of plasma exchange by which plasma is first removed and then passed over columns with specific ligands (for example

OpenPR | September 15, 2021

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 1.0091 seconds.